Literature DB >> 2357675

Cholestatic jaundice associated with lovastatin (mevacor) therapy.

J A Geddes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2357675      PMCID： PMC1452071     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Cholestatic jaundice associated with lovastatin (Mevacor) therapy.

Authors:  M J McQueen
Journal:  CMAJ       Date:  1990-04-15       Impact factor: 8.262
  1 in total
  3 in total

1.  Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Authors:  Anita Conforti; Lara Magro; Ugo Moretti; Stefania Scotto; Domenico Motola; Francesco Salvo; Barbara Ros; Roberto Leone
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Lovastatin and cholestasis.

Authors:  E M Yoshida; A Levin
Journal:  CMAJ       Date:  1993-02-01       Impact factor: 8.262

3.  Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Rosanna Villani; Eliano Pio Navarese; Francesco Cavallone; Jacek Kubica; Francesco Bellanti; Antonio Facciorusso; Gianluigi Vendemiale; Gaetano Serviddio
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.